AU782785B2 - Treatment of obesity by bilateral vagus nerve stimulation - Google Patents
Treatment of obesity by bilateral vagus nerve stimulation Download PDFInfo
- Publication number
- AU782785B2 AU782785B2 AU68028/00A AU6802800A AU782785B2 AU 782785 B2 AU782785 B2 AU 782785B2 AU 68028/00 A AU68028/00 A AU 68028/00A AU 6802800 A AU6802800 A AU 6802800A AU 782785 B2 AU782785 B2 AU 782785B2
- Authority
- AU
- Australia
- Prior art keywords
- electrical signal
- vagi
- patient
- stimulating
- pulses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000001186 vagus nerve Anatomy 0.000 title claims description 26
- 208000008589 Obesity Diseases 0.000 title claims description 24
- 230000002146 bilateral effect Effects 0.000 title claims description 22
- 235000020824 obesity Nutrition 0.000 title claims description 19
- 230000007383 nerve stimulation Effects 0.000 title description 8
- 238000000034 method Methods 0.000 claims description 53
- 230000000638 stimulation Effects 0.000 claims description 40
- 230000004936 stimulating effect Effects 0.000 claims description 38
- 210000005036 nerve Anatomy 0.000 claims description 29
- 230000001684 chronic effect Effects 0.000 claims description 10
- 235000019627 satiety Nutrition 0.000 claims description 10
- 230000036186 satiety Effects 0.000 claims description 10
- 206010038776 Retching Diseases 0.000 claims description 9
- 206010020710 Hyperphagia Diseases 0.000 claims description 8
- 235000020830 overeating Nutrition 0.000 claims description 8
- 235000014632 disordered eating Nutrition 0.000 claims description 7
- 230000035807 sensation Effects 0.000 claims description 7
- 235000019615 sensations Nutrition 0.000 claims description 7
- 210000002784 stomach Anatomy 0.000 claims description 5
- 230000002060 circadian Effects 0.000 claims description 4
- 238000002513 implantation Methods 0.000 claims description 2
- 208000010235 Food Addiction Diseases 0.000 claims 2
- 210000001835 viscera Anatomy 0.000 claims 1
- 230000001515 vagal effect Effects 0.000 description 21
- 230000020595 eating behavior Effects 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 13
- 235000013305 food Nutrition 0.000 description 12
- 230000007774 longterm Effects 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 241000282472 Canis lupus familiaris Species 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000008242 dietary patterns Nutrition 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000030814 Eating disease Diseases 0.000 description 5
- 208000019454 Feeding and Eating disease Diseases 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 208000001022 morbid obesity Diseases 0.000 description 5
- 208000012696 congenital leptin deficiency Diseases 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 230000007384 vagal nerve stimulation Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 2
- 238000009223 counseling Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 230000035611 feeding Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 235000019525 fullness Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000013585 weight reducing agent Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ITZMJCSORYKOSI-AJNGGQMLSA-N APGPR Enterostatin Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 ITZMJCSORYKOSI-AJNGGQMLSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010004716 Binge eating Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 102100025841 Cholecystokinin Human genes 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 208000014679 binge eating disease Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940107137 cholecystokinin Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 231100000867 compulsive behavior Toxicity 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 210000000412 mechanoreceptor Anatomy 0.000 description 1
- 108091008704 mechanoreceptors Proteins 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003880 negative regulation of appetite Effects 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003957 neurotransmitter release Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010070701 procolipase Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000036279 refractory period Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/040301 WO2002004068A1 (en) | 2000-07-06 | 2000-07-06 | Treatment of obesity by bilateral vagus nerve stimulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6802800A AU6802800A (en) | 2002-01-21 |
| AU782785B2 true AU782785B2 (en) | 2005-08-25 |
Family
ID=21742130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU68028/00A Ceased AU782785B2 (en) | 2000-07-06 | 2000-07-06 | Treatment of obesity by bilateral vagus nerve stimulation |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1296743A1 (https=) |
| JP (1) | JP2004502506A (https=) |
| AU (1) | AU782785B2 (https=) |
| CA (1) | CA2401098C (https=) |
| WO (1) | WO2002004068A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7117033B2 (en) | 2000-05-08 | 2006-10-03 | Brainsgate, Ltd. | Stimulation for acute conditions |
| US6609025B2 (en) * | 2001-01-02 | 2003-08-19 | Cyberonics, Inc. | Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation |
| US6754536B2 (en) | 2001-01-31 | 2004-06-22 | Medtronic, Inc | Implantable medical device affixed internally within the gastrointestinal tract |
| US7167751B1 (en) | 2001-03-01 | 2007-01-23 | Advanced Bionics Corporation | Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation |
| US7937145B2 (en) | 2002-03-22 | 2011-05-03 | Advanced Neuromodulation Systems, Inc. | Dynamic nerve stimulation employing frequency modulation |
| US7689276B2 (en) | 2002-09-13 | 2010-03-30 | Leptos Biomedical, Inc. | Dynamic nerve stimulation for treatment of disorders |
| US7689277B2 (en) | 2002-03-22 | 2010-03-30 | Leptos Biomedical, Inc. | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
| US7551964B2 (en) | 2002-03-22 | 2009-06-23 | Leptos Biomedical, Inc. | Splanchnic nerve stimulation for treatment of obesity |
| US7702386B2 (en) | 2002-03-22 | 2010-04-20 | Leptos Biomedical, Inc. | Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes |
| US7239912B2 (en) | 2002-03-22 | 2007-07-03 | Leptos Biomedical, Inc. | Electric modulation of sympathetic nervous system |
| US7236822B2 (en) | 2002-03-22 | 2007-06-26 | Leptos Biomedical, Inc. | Wireless electric modulation of sympathetic nervous system |
| US20080077192A1 (en) | 2002-05-03 | 2008-03-27 | Afferent Corporation | System and method for neuro-stimulation |
| US7561919B2 (en) | 2002-11-14 | 2009-07-14 | Brainsgate Ltd. | SPG stimulation via the greater palatine canal |
| WO2004064918A1 (en) | 2003-01-14 | 2004-08-05 | Department Of Veterans Affairs, Office Of General Counsel | Cervical wagal stimulation induced weight loss |
| US7725176B2 (en) | 2003-07-10 | 2010-05-25 | Schuler Eleanor L | Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals |
| US9254388B2 (en) | 2003-07-10 | 2016-02-09 | Codes Of Life, Llc | Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals |
| US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
| US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
| US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
| US7623924B2 (en) | 2004-08-31 | 2009-11-24 | Leptos Biomedical, Inc. | Devices and methods for gynecologic hormone modulation in mammals |
| US8295926B2 (en) | 2006-06-02 | 2012-10-23 | Advanced Neuromodulation Systems, Inc. | Dynamic nerve stimulation in combination with other eating disorder treatment modalities |
| US8321030B2 (en) | 2009-04-20 | 2012-11-27 | Advanced Neuromodulation Systems, Inc. | Esophageal activity modulated obesity therapy |
| EP2878335B1 (en) | 2013-11-10 | 2018-01-03 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| US10271907B2 (en) | 2015-05-13 | 2019-04-30 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| US11154238B2 (en) | 2015-08-07 | 2021-10-26 | Electroceuticals, Llc | Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5188104A (en) * | 1991-02-01 | 1993-02-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
| US5263480A (en) * | 1991-02-01 | 1993-11-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
| US5330507A (en) * | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5035437A (en) | 1989-11-13 | 1991-07-30 | Outboard Marine Corporation | Outboard motor carrier |
| US5540730A (en) * | 1995-06-06 | 1996-07-30 | Cyberonics, Inc. | Treatment of motility disorders by nerve stimulation |
-
2000
- 2000-07-06 WO PCT/US2000/040301 patent/WO2002004068A1/en not_active Ceased
- 2000-07-06 EP EP00955908A patent/EP1296743A1/en not_active Withdrawn
- 2000-07-06 JP JP2002508519A patent/JP2004502506A/ja active Pending
- 2000-07-06 CA CA2401098A patent/CA2401098C/en not_active Expired - Lifetime
- 2000-07-06 AU AU68028/00A patent/AU782785B2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5188104A (en) * | 1991-02-01 | 1993-02-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
| US5263480A (en) * | 1991-02-01 | 1993-11-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
| US5330507A (en) * | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004502506A (ja) | 2004-01-29 |
| WO2002004068A1 (en) | 2002-01-17 |
| CA2401098A1 (en) | 2002-01-17 |
| EP1296743A1 (en) | 2003-04-02 |
| AU6802800A (en) | 2002-01-21 |
| CA2401098C (en) | 2012-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7299091B2 (en) | Treatment of obesity by bilateral vagus nerve stimulation | |
| AU782785B2 (en) | Treatment of obesity by bilateral vagus nerve stimulation | |
| AU2002246933B2 (en) | Treatment of obesity by sub-diaphragmatic nerve stimulation | |
| US10376694B2 (en) | Method and apparatus for stimulating the vascular system | |
| US9037244B2 (en) | Method and apparatus for electrical stimulation of the pancreatico-biliary system | |
| US7835796B2 (en) | Weight loss method and device | |
| US7310557B2 (en) | Identification of electrodes for nerve stimulation in the treatment of eating disorders | |
| US7899540B2 (en) | Noninvasively adjustable gastric band | |
| US5690691A (en) | Gastro-intestinal pacemaker having phased multi-point stimulation | |
| AU2002246933A1 (en) | Treatment of obesity by sub-diaphragmatic nerve stimulation | |
| Roslin et al. | Vagus nerve stimulation in the treatment of morbid obesity | |
| Roslin et al. | The use of electrical stimulation to treat morbid obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |